SAB Biotherapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $172.8M
Liabilities Breakdown FY2025
Total Liabilities: $21.3M
Asset Breakdown
Total Assets: $172.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $10.5M | 6.1% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $13.3M | 7.7% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $149.0M | 86.2% |
Liabilities Breakdown
Total Liabilities: $21.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.1M | 14.8% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $18.2M | 85.2% |